FDA Adverse Event Malfunction Summary report: N

ELECSYS ¿-CROSSLAPS/SERUM IMMUNOASSAY

MDR report key: 9152004 · Received October 3, 2019

Report

Report Number
1823260-2019-03556
Event Type
Malfunction
Date Received
October 3, 2019
Date of Event
May 31, 2019
Report Date
February 4, 2020
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JMM
PMA / PMN Number
K993706
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

THE QC DATA PROVIDED FROM THE E801 MODULE WAS ACCEPTABLE. A SAMPLE WAS RETURNED FOR INVESTIGATION. THE INVESTIGATION CONFIRMED THE CUSTOMER¿S RESULTS. A HETEROPHILIC INTERFERENCE WAS FOUND IN THE SAMPLE. THE INTERFERENCE IS DESCRIBED IN THE PRODUCT LABELING: IN RARE CASES, INTERFERENCE DUE TO EXTREMELY HIGH TITERS OF ANTIBODIES TO ANALYTE-SPECIFIC ANTIBODIES, STREPTAVIDIN OR RUTHENIUM CAN OCCUR. THESE EFFECTS ARE MINIMIZED BY SUITABLE TEST DESIGN.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6). THE CUSTOMER PERFORMED A NEUTRALIZATION PROCEDURE ON THE PATIENT SAMPLE IN AN ATTEMPT TO ELIMINATE THE INTERFERENCE WITH NO SUCCESS.

Description of Event or Problem · 1

THE INITIAL REPORTER COMPLAINED OF DISCREPANT HIGH RESULTS FOR 1 PATIENT TESTED FOR ELECSYS B-CROSSLAPS/SERUM (B-CROSSLAPS) ON A COBAS E 801 MODULE COMPARED TO A COBAS E 411 IMMUNOASSAY ANALYZER. THE INITIAL RESULT FROM THE E801 MODULE WAS > 6000 PG/ML. SINCE THIS RESULT DID NOT CORRESPOND TO THE PATIENT'S CLINICAL PICTURE, A NEW SAMPLE WAS REQUESTED. ON (B)(6) 2019 A NEW SAMPLE WAS OBTAINED AND THE RESULT ON THE E801 MODULE WAS 5598 PG/ML. THIS SAMPLE WAS REPEATED ON AN E411 ANALYZER IN A DIFFERENT LABORATORY AND THE RESULT WAS 389.4 PG/ML. THIS RESULT WAS BELIEVED TO BE CORRECT. THE CUSTOMER SUSPECTS AN INTERFERENCE OF THE PATIENT SAMPLE AND THE E801 MODULE METHODOLOGY. THE E801 MODULE SERIAL NUMBER IS (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
948320 ELECSYS ¿-CROSSLAPS/SERUM IMMUNOASSAY COLUMN CHROMATOGRAPHY & COLOR DEVELOPMENT, HYDROXYPROLINE JMM ROCHE DIAGNOSTICS NA 349942

Patients

Seq Age Sex Outcome Treatment
1 77 YR